Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal

Patrick Lemoine1, Doron Garfinkel2, Moshe Laudon3, Tali Nir3, Nava Zisapel3,41The Clinique Lyon-Lumière, Meyzieu, France; 2Geriatric-Palliative Department, Shoham Geriatric Medical Center, Pardes Hanna, Israel; 3Neurim Pharmaceuticals Ltd, Tel-Aviv, Israel; 4Department of Neurobiology...

Full description

Bibliographic Details
Main Authors: Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N
Format: Article
Language:English
Published: Dove Medical Press 2011-07-01
Series:Therapeutics and Clinical Risk Management
Online Access:http://www.dovepress.com/prolonged-release-melatonin-for-insomnia-ndash-an-open-label-long-term-a7956

Internet

http://www.dovepress.com/prolonged-release-melatonin-for-insomnia-ndash-an-open-label-long-term-a7956

Similar Items